Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomized controlled trial of methylprednisolone versus dexamethasone in COVID-19 pneumonia
2020-006054-43Phase 3Completed
- Sponsor
- University of Trieste
- Start
- Mar 2021
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in coronavirus pneumonia and coronavirus disease 2019 (COVID-19) comparing Methylprednisolone protocol with Dexamethasone protocol (2 arms). Primary endpoint: 28-day survival proportion. Started Mar 2021; status: completed.
02
Drugs
methylprednisolonedexamethasone
03
Conditions
coronavirus pneumoniacoronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on 2020-006054-43.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-006054-43.